Luck Lori, Zeng Licheng, Hiti Alan L, Weinberg Kenneth I, Malik Punam
Division of Hematology-Oncology, Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.
Exp Hematol. 2004 May;32(5):483-93. doi: 10.1016/j.exphem.2004.02.003.
Sickle cell disease (SCD) is remarkable for stress erythropoiesis. We investigated the progenitor populations contributing to erythroid stress.
We characterized hematopoietic progenitor cells in sickle bone marrow and sickle peripheral blood from patients with SCD compared to those in normal bone marrow.
There were increased proportions of sickle bone marrow and sickle peripheral blood CD34(+) cells that coexpressed glycophorin A (GlyA), normally expressed late during erythroid differentiation when CD34 is down-regulated. Remarkably, increased numbers of CD34(+)CD38(-) hematopoietic progenitor cells from sickle bone marrow (p < 0.03) and sickle peripheral blood (p < 0.004) coexpressed GlyA, compared to normal bone marrow CD34(+)CD38(-) hematopoietic progenitor cells. At a molecular level, even the sickle bone marrow and sickle peripheral blood CD34(+)CD38(-) hematopoietic progenitor cells not expressing GlyA by fluorescence-activated cell sorting or reverse transcriptase-polymerase chain reaction expressed the erythroid-specific gene GATA-1, unlike normal bone marrow, suggesting desynchronized erythroid gene expression in the SCD hematopoietic progenitor cells. We also generated red blood cells in vitro from GlyA(+) and GlyA(-)CD34(+) cells. GlyA(+)CD34(+) produced more F cells (p < 0.02) and had lower clonogenicity (p < 0.01) and erythroid expansion potential. Increased F cells were generated only from sickle CD34(+) hematopoietic progenitor cells (p < 0.04), as occurs in vivo.
Stress erythropoiesis in SCD has been postulated to accelerate erythropoiesis and production of F cells. Thus, CD34(+)CD38(-) expressing GlyA may represent the "stress progenitor" population. This is the first study characterizing CD34(+) and CD34(+)CD38(-) hematopoietic progenitor cells in sickle bone marrow, comparing them to sickle peripheral blood and normal bone marrow and using them to generate sickle red blood cells that recapitulate F cell production observed in vivo. We identified a unique population of GlyA(+)CD34(+) cells in SCD, which is in an accelerated erythroid differentiation pathway, has not down-regulated CD34 antigen expression, and predominantly generates F cells.
镰状细胞病(SCD)以应激性红细胞生成显著为特点。我们研究了参与红细胞应激的祖细胞群体。
我们对SCD患者的镰状骨髓和镰状外周血中的造血祖细胞进行了特征分析,并与正常骨髓中的造血祖细胞进行比较。
镰状骨髓和镰状外周血中共同表达血型糖蛋白A(GlyA)的CD34(+)细胞比例增加,而GlyA通常在红细胞分化后期、CD34下调时表达。值得注意的是,与正常骨髓CD34(+)CD38(-)造血祖细胞相比,镰状骨髓(p < 0.03)和镰状外周血(p < 0.004)中共同表达GlyA的CD34(+)CD38(-)造血祖细胞数量增加。在分子水平上,即使通过荧光激活细胞分选或逆转录聚合酶链反应未表达GlyA的镰状骨髓和镰状外周血CD34(+)CD38(-)造血祖细胞也表达红细胞特异性基因GATA-1,这与正常骨髓不同,表明SCD造血祖细胞中红细胞基因表达失调。我们还从GlyA(+)和GlyA(-)CD34(+)细胞体外生成了红细胞。GlyA(+)CD34(+)产生了更多F细胞(p < 0.02),且克隆形成能力较低(p < 0.01)和红细胞扩增潜力较低。仅镰状CD34(+)造血祖细胞产生了更多F细胞(p < 0.04),这与体内情况一致。
SCD中的应激性红细胞生成被推测可加速红细胞生成和F细胞的产生。因此,表达GlyA的CD34(+)CD38(-)细胞可能代表“应激祖细胞”群体。这是第一项对镰状骨髓中的CD34(+)和CD34(+)CD38(-)造血祖细胞进行特征分析的研究,将它们与镰状外周血和正常骨髓进行比较,并利用它们生成了在体内观察到的可重现F细胞产生的镰状红细胞。我们在SCD中鉴定出了独特的GlyA(+)CD34(+)细胞群体,其处于加速的红细胞分化途径中,尚未下调CD34抗原表达,且主要产生F细胞。